Reactive Centre Loop Dynamics and Serpin Specificity

Citations Over Time

Abstract

Abstract Serine proteinase inhibitors (serpins), typically fold to a metastable native state and undergo a major conformational change in order to inhibit target proteases. However, conformational labiality of the native serpin fold renders them susceptible to misfolding and aggregation, and underlies misfolding diseases such as a1-antitrypsin deficiency. Serpin specificity towards its protease target is dictated by its flexible and solvent exposed reactive centre loop (RCL), which forms the initial interaction with the target protease during inhibition. Previous studies have attempted to alter the specificity by mutating the RCL to that of a target serpin, but the rules governing specificity are not understood well enough yet to enable specificity to be engineered at will. In this paper, we use conserpin , a synthetic, thermostable serpin, as a model protein with which to investigate the determinants of serpin specificity by engineering its RCL. Replacing the RCL sequence with that from α1-antitrypsin fails to restore specificity against trypsin or human neutrophil elastase. Structural determination of the RCL-engineered conserpin and molecular dynamics simulations indicate that, although the RCL sequence may partially dictate specificity, local electrostatics and RCL dynamics may dictate the rate of insertion during protease inhibition, and thus whether it behaves as an inhibitor or a substrate. Engineering serpin specificity is therefore substantially more complex than solely manipulating the RCL sequence, and will require a more thorough understanding of how conformational dynamics achieves the delicate balance between stability, folding and function required by the exquisite serpin mechanism of action.

Related Papers

• → The intact and cleaved human antithrombin III complex as a model for serpin–proteinase interactions(1994)280 cited
• → The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition(1998)80 cited
• → PLANT SERPINS AS POTENTIAL PHARMACEUTICALS FOR THE CORRECTION OF HEMOSTASIS AND FIBRINOLYSIS DISTURBANCES. BIOINFORMATIC STUDY(2016)4 cited
• → The structural puzzle of how serpin serine proteinase inhibitors work(1996)68 cited
• Recombinant expression and functional characterization of a Serpin-type serine proteinase inhibitor(Fc-serpin) from the Chinese shrimp(Fenneropenaeus chinensis)(2013)